ES2065341T3 - Vectores y compuestos para la expresion de formas zimogenas de proteina c humana. - Google Patents

Vectores y compuestos para la expresion de formas zimogenas de proteina c humana.

Info

Publication number
ES2065341T3
ES2065341T3 ES88312201T ES88312201T ES2065341T3 ES 2065341 T3 ES2065341 T3 ES 2065341T3 ES 88312201 T ES88312201 T ES 88312201T ES 88312201 T ES88312201 T ES 88312201T ES 2065341 T3 ES2065341 T3 ES 2065341T3
Authority
ES
Spain
Prior art keywords
vectors
compounds
human protein
forms
zimogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88312201T
Other languages
English (en)
Inventor
Nils Ulrik Bang
Hartmut Josef Ehrlich
Brian William Grinnell
Sau-Chi Betty Yan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2065341T3 publication Critical patent/ES2065341T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN METODO PARA LA PRODUCCION RECOMBINANTE DE FORMAS ZIMOGENAS DE PROTEINA C HUMANA. ESTAS FORMAS ZIMOGENAS DIFIEREN DE LA PROTEINA C ZIMOGENA NATIVA EN SU MAYOR SENSIBILIDAD A ACTIVACION POR TROMBINA Y TROMBINA/TROMBOMODULINA. TAMBIEN SE PRESENTAN COMPUESTOS ADN, VECTORES Y TRANSFORMANTE UTILES EN EL METODO.
ES88312201T 1987-12-28 1988-12-22 Vectores y compuestos para la expresion de formas zimogenas de proteina c humana. Expired - Lifetime ES2065341T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13800987A 1987-12-28 1987-12-28

Publications (1)

Publication Number Publication Date
ES2065341T3 true ES2065341T3 (es) 1995-02-16

Family

ID=22480037

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88312201T Expired - Lifetime ES2065341T3 (es) 1987-12-28 1988-12-22 Vectores y compuestos para la expresion de formas zimogenas de proteina c humana.

Country Status (21)

Country Link
EP (1) EP0323149B1 (es)
JP (1) JP2851287B2 (es)
KR (1) KR890010202A (es)
CN (1) CN1035526A (es)
AR (1) AR244804A1 (es)
AT (1) ATE116368T1 (es)
AU (1) AU609919B2 (es)
CA (1) CA1340111C (es)
DE (1) DE3852625T2 (es)
DK (1) DK723488A (es)
ES (1) ES2065341T3 (es)
GR (1) GR3015609T3 (es)
HU (1) HU210863B (es)
IE (1) IE66337B1 (es)
IL (1) IL88758A (es)
MX (1) MX14312A (es)
NZ (1) NZ227434A (es)
PT (1) PT89285B (es)
RU (1) RU2018535C1 (es)
SU (1) SU1739854A3 (es)
ZA (1) ZA889497B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012685A1 (en) * 1987-05-18 1989-12-28 Integrated Genetics, Inc. Improved protein c molecules and method for making and activating same
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
ATE163048T1 (de) * 1989-12-29 1998-02-15 Zymogenetics Inc Hybrides protein c
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
US5270178A (en) * 1990-02-23 1993-12-14 Eli Lilly And Company Vectors and compounds for expression of zymogen forms of human protein C
IL97311A0 (en) * 1990-02-23 1992-05-25 Lilly Co Eli Vectors and compounds for expression of glycosylation mutants of human protein c
MY110664A (en) * 1992-05-21 1999-01-30 Lilly Co Eli Protein c derivatives
US5618714A (en) * 1993-12-15 1997-04-08 Eli Lilly And Company Methods for producing protein C
RU2214833C2 (ru) * 1994-10-24 2003-10-27 Ново Нордиск Хелс Кеар Аг Модифицированный фактор vii
CA2391651A1 (en) * 1999-11-19 2001-05-25 Eli Lilly And Company Protein c derivatives
ATE469216T1 (de) * 2004-08-17 2010-06-15 Csl Behring Gmbh Modifizierte vitamin-k-abhängige polypeptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C

Also Published As

Publication number Publication date
NZ227434A (en) 1991-03-26
EP0323149A2 (en) 1989-07-05
JPH022376A (ja) 1990-01-08
EP0323149B1 (en) 1994-12-28
PT89285B (pt) 1993-08-31
GR3015609T3 (en) 1995-06-30
CA1340111C (en) 1998-11-03
SU1739854A3 (ru) 1992-06-07
PT89285A (pt) 1989-12-29
RU2018535C1 (ru) 1994-08-30
ATE116368T1 (de) 1995-01-15
HU210863B (en) 1995-08-28
IL88758A0 (en) 1989-07-31
DE3852625T2 (de) 1995-05-24
IE66337B1 (en) 1995-12-27
AU609919B2 (en) 1991-05-09
AR244804A1 (es) 1993-11-30
AU2732988A (en) 1989-06-29
IE883849L (en) 1989-06-28
EP0323149A3 (en) 1990-06-13
JP2851287B2 (ja) 1999-01-27
CN1035526A (zh) 1989-09-13
IL88758A (en) 1994-02-27
KR890010202A (ko) 1989-08-07
MX14312A (es) 1994-01-31
DE3852625D1 (de) 1995-02-09
ZA889497B (en) 1990-08-29
DK723488D0 (da) 1988-12-27
DK723488A (da) 1989-06-29
HUT50499A (en) 1990-02-28

Similar Documents

Publication Publication Date Title
DE3382837D1 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
ES2065341T3 (es) Vectores y compuestos para la expresion de formas zimogenas de proteina c humana.
DK457587A (da) Fremgangsmaade til fremstilling af et protein af faktor viii:c-typen
ES2114539T3 (es) Expresion de polipeptidos recombinados con purificacion mejorada.
ES2038966T3 (es) Expresion y secrecion de proteinas heterologas mediante transformantes de yarrowia lipolytica.
ES2072900T3 (es) Expresion elevada de proteinas en levadura.
FI101720B1 (fi) Synteettisen DNA:n konstruointi ja sen käyttö suurten polypeptidien synteesissä
ES2115662T3 (es) Modificacion genetica de celulas endoteliales.
ES2078907T3 (es) Metodo para radiomarcar proteinas.
DE69329202D1 (de) Methoden der erhöhung der sekretion von überexpremierten proteinen
ES2061482T3 (es) Metodo para la identificacion de secuencias de señal secretora para sintesis de proteina extracelular en bacillus.
FI855141A7 (fi) Rekombinantti-DNA-vektoreita, jotka kykenevät ilmaisemaan apoaequoriinia.
NO885326L (no) Human vevfaktor-beslektede dna-segmenter, polypeptider ogantistoffer.
DE3884529D1 (de) Leader-anteile zur produktion von rekombinanten proteinen.
ES2184728T3 (es) Proteinas de union a la fibronectina.
YU31791A (sh) Vektori i jedinjenja za ekspresiju zimogenih oblika humanog proteina c
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
ES2101716T3 (es) Vectores y compuestos para la expresion de mutantes de glicosilacion de la proteina c humana.
ES2072928T3 (es) Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular.
DK638187D0 (da) Hybridproteiner
DE3585657D1 (de) Gegenseitige trennung von proteinen.
FI911882A0 (fi) Foerfarande foer framstaellning av fraemmande proteiner i streptomyceter.
ES2061719T3 (es) Proceso para la produccion de proteinas.
ES2131041T3 (es) Peptidos anticoagulantes.
ES2052513T3 (es) Nuevos polipeptidos, su fabricacion y empleo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 323149

Country of ref document: ES